Searched for
CAPLIN STERILES LIMITED
Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...- Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsHistory suggests that market recoveries are led by large-cap stocks. But, in the past two years, there have been phases where the rally and...
- Weekly Top mid and smallcap picks: These mid and smallcap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These mid and small cap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These mid and small cap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Stock picks of the week: 4 stocks with consistent score improvement and upside potential of up to 23%As broader market indices witness minor consolidation, which normally happens when they are close to all time high as some resistance is bo...
- Caplin Point Labs' subsidiary inks distribution pact with Xellia Pharma for 5 injectables in USThe first product is expected to be launched shortly, while approvals for the remaining are expected in the next 12-18 months, Caplin Point...
- Eight Roads leads Rs 45 crore Series A funding round in Ashish Life ScienceThe investment is the second by the marquee investor in India's broader pharmaceutical sector.
Load More
